Federal contractor profile
NEUROHOPE THERAPEUTICS, INC.
UEI YH1JEE27ME68CAGE 03W69
Active
Woman Owned Small BusinessWoman Owned BusinessSmall Business
Overview
- Legal name
- NEUROHOPE THERAPEUTICS, INC.
- Registered location
- GREENVILLE, SC, USA
- Primary NAICS
- 541713 — Research and Development in Nanotechnology
- Latest award activity
- May 26, 2026
Read company summary
NEUROHOPE THERAPEUTICS, INC. is associated with UEI YH1JEE27ME68 and CAGE 03W69 in public federal records. AcornBids currently links 2 prime awards totaling $1.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541713 (Research and Development in Nanotechnology). Its public SAM.gov registration lists GREENVILLE, SC, USA.
At a glance
Lifetime prime obligations$1.5M
Prime awards2
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- NEUROHOPE THERAPEUTICS, INC.
- UEI
- YH1JEE27ME68
- CAGE
- 03W69
- Registered address
- 6 MONET DR, GREENVILLE, SC, 29609, USA
- Registration status
- Active
- Primary NAICS
- 541713 — Research and Development in Nanotechnology
- SAM activation
- Jul 23, 2026
- Initial registration
- Dec 14, 2022
- Entity start
- Oct 31, 2022
- SAM updated
- Jul 23, 2026
- Registration expires
- Jul 22, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HT942726CE012DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY | Department of Defense | $1.3M | Apr 6, 2026 | Aug 5, 2028 |
| HT942525P0023DHA SBIR PHASE I FOR PROJECT TITLED, "DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY" | Department of Defense | $249.5K | Jan 27, 2025 | Sep 2, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 23, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Dec 14, 2022 |
| Entity start | Oct 31, 2022 |
Registration classifications: Woman Owned Small Business, Woman Owned Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541713 — Research and Development in Nanotechnology | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| CHARLES K WEBB | Government business | Contact method not published | SAM registration | Not available |
| CHARLES K WEBB | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541713 — Research and Development in Nanotechnology
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
376 awards
207 awards
147 awards
131 awards
119 awards
104 awards
About NEUROHOPE THERAPEUTICS, INC.
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
- DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY
- DHA SBIR PHASE I FOR PROJECT TITLED, "DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY"
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
6 MONET DR, GREENVILLE, South Carolina 29609, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541713 — Research and Development in Nanotechnology.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit